Valneva reports first quarter 2025 financial results and provides corporate updates

Saint-herblain (france), may 7, 2025 – valneva se (nasdaq: valn; euronext paris: vla), a specialty vaccine company, today reported its financial results for the first quarter ending march 31, 2025, provided key corporate updates and confirmed its 2025 financial guidance. the condensed consolidated interim financial results are available on the company's website (financial reports – valneva).
VALN Ratings Summary
VALN Quant Ranking